Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.73 - $3.09 $229,410 - $409,755
-132,607 Reduced 14.07%
809,651 $1.56 Million
Q4 2021

Feb 14, 2022

BUY
$4.07 - $5.3 $2.07 Million - $2.69 Million
508,454 Added 117.21%
942,258 $4.23 Million
Q3 2017

Nov 14, 2017

BUY
$18.9 - $28.2 $8.2 Million - $12.2 Million
433,804
433,804 $10.9 Million

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Fortress Investment Group LLC Portfolio

Follow Fortress Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortress Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortress Investment Group LLC with notifications on news.